1. Home
  2. EBS vs RFI Comparison

EBS vs RFI Comparison

Compare EBS & RFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBS
  • RFI
  • Stock Information
  • Founded
  • EBS 1998
  • RFI 1992
  • Country
  • EBS United States
  • RFI United States
  • Employees
  • EBS N/A
  • RFI N/A
  • Industry
  • EBS Biotechnology: Pharmaceutical Preparations
  • RFI Investment Managers
  • Sector
  • EBS Health Care
  • RFI Finance
  • Exchange
  • EBS Nasdaq
  • RFI Nasdaq
  • Market Cap
  • EBS 359.3M
  • RFI 322.1M
  • IPO Year
  • EBS 2006
  • RFI N/A
  • Fundamental
  • Price
  • EBS $8.15
  • RFI $12.03
  • Analyst Decision
  • EBS Strong Buy
  • RFI
  • Analyst Count
  • EBS 3
  • RFI 0
  • Target Price
  • EBS $14.33
  • RFI N/A
  • AVG Volume (30 Days)
  • EBS 1.0M
  • RFI 69.8K
  • Earning Date
  • EBS 11-05-2025
  • RFI 01-01-0001
  • Dividend Yield
  • EBS N/A
  • RFI 8.25%
  • EPS Growth
  • EBS N/A
  • RFI N/A
  • EPS
  • EBS 2.53
  • RFI N/A
  • Revenue
  • EBS $851,600,000.00
  • RFI N/A
  • Revenue This Year
  • EBS N/A
  • RFI N/A
  • Revenue Next Year
  • EBS $19.24
  • RFI N/A
  • P/E Ratio
  • EBS $3.25
  • RFI N/A
  • Revenue Growth
  • EBS N/A
  • RFI N/A
  • 52 Week Low
  • EBS $4.02
  • RFI $9.62
  • 52 Week High
  • EBS $12.73
  • RFI $12.52
  • Technical
  • Relative Strength Index (RSI)
  • EBS 51.40
  • RFI 53.96
  • Support Level
  • EBS $7.45
  • RFI $11.89
  • Resistance Level
  • EBS $8.62
  • RFI $12.07
  • Average True Range (ATR)
  • EBS 0.40
  • RFI 0.12
  • MACD
  • EBS -0.10
  • RFI 0.00
  • Stochastic Oscillator
  • EBS 38.46
  • RFI 51.85

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

About RFI Cohen & Steers Total Return Realty Fund Inc.

Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.

Share on Social Networks: